Abstract
Purpose
A magnetic resonance imaging contrast agent based on a tetrameric Gd-DTPA-like system linked to a fibrin-targeting peptide (Gd-F) has been designed for in vivo tumor characterization.
Procedures
Gd-F was synthesized following Fmoc-SPPS strategy. Binding was measured using soluble fibrin DD(E) fragment and a dried fibrin assay. Contrast efficiency was tested on human and mouse clots and in vivo on Neuro2A tumor model. An anti-thrombotic drug was used to evaluate Gd-F sensitivity for changes in fibrin availability at the tumor site.
Results
The high relaxivity of Gd-F (42 mM−1 s−1, per molecule) yielded a strong signal enhancement in human and murine clots. High contrast was also measured in vivo in Neuro2A tumors, with a persistent enhancement in tumor rim and stroma. Upon treatment with an anti-thrombotic drug, the contrast uptake was significantly reduced in the tumor area confirming the specificity of the probe.
Conclusions
Gd-F resulted to be an efficient probe for tumor delineation and for monitoring fibrin deposits during tumor progression and anti-thrombotic therapy.
Similar content being viewed by others
References
Nagy JA, Brown LF, Senger DR et al (1989) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948:305–326
Costantini V, Zacharski LR (1992) The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11:283–290
Caine GJ, Stonelake PS, Lip GY et al (2002) The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 4:465–473
Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11:223–233
Yu X, Song SK, Chen J et al (2000) High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 44:867–872
Flacke S, Fischer S, Scott MJ et al (2001) Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104:1280–1285
Sirol M, Aguinaldo JG, Graham PB et al (2005) Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis 182:79–85
Ciesienski KL, Yang Y, Ay I et al (2013) Fibrin-targeted PET probes for the detection of thrombi. Mol Pharm 10:1100–1110
Starmans LW, van Duijnhoven SM, Rossin R et al (2013) SPECT imaging of fibrin using fibrin-binding peptides. Contrast Media Mol Imaging 8:229–237
Starmans LW, van Duijnhoven SM, Rossin R et al (2013) Evaluation of 111In-labelled EPep and FibPep as tracers for fibrin PECT imaging. Mol Pharm 10:4309–4321
Jaffer FA, Tung CH, Wykrzykowska JJ et al (2004) Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110:170–176
Hara T, Bhayana B, Thompson B et al (2012) Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc Imaging 5:607–615
Botnar RM, Perez AS, Witte S et al (2004) In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109:2023–2029
Sirol M, Fuster V, Badimon JJ et al (2005) Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 112:1594–1600
Spuentrup E, Buecker A, Katoh M et al (2005) Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 111:1377–1382
Stracke CP, Katoh M, Wiethoff AJ et al (2007) Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent. Stroke 38:1476–1481
Overoye-Chan K, Koerner S, Looby RJ et al (2008) EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc 130:6025–6039
Uppal R, Ay I, Dai G et al (2010) Molecular MRI of intracranial thrombus in a rat ischemic stroke model. Stroke 41:1271–1277
Spuentrup E, Botnar RM, Wiethoff AJ et al (2008) MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 18:1995–2005
Vymazal J, Spuentrup E, Cardenas-Molina G et al (2009) Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Investig Radiol 44:697–704
Morelli JN, Runge VM, Williams JM et al (2011) Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model. Investig Radiol 46:169–177
Tan M, Burden-Gulley SM, Li W et al (2012) MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharm Res 29:953–960
Uppal R, Medarova Z, Farrar CT et al (2012) Molecular imaging of fibrin in a breast cancer xenograft mouse model. Investig Radiol 47:553–558
Chow AM, Tan M, Gao DS et al (2013) Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model. Investig Radiol 48:46–54
Villaraza AJ, Bumb A, Brechbiel MW (2010) Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 110:2921–2959
Botta M, Tei L (2012) Relaxivity enhancement in macromolecular and nanosized GdIII-based MRI Contrast Agents. Eur J Inorg Chem. 1945–1960
Wescott CR, Beltzer JP, Sato AK, Dyax Corp (2002) Fibrin binding moieties useful as imaging agents. Patent WO 02/055544 A2
Anelli PL, Fedeli F, Gazzotti O et al (1999) L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands. Bioconjug Chem 10:137–140
Lattuada L, Barge A, Cravotto G et al (2011) The synthesis and application of polyamino polycarboxylic bifunctional chelating agents. Chem Soc Rev 40:3019–3049
Barge A, Cravotto G, Gianolio E et al (2006) How to determine free Gd and free ligand in solution of Gd chelates. A technical note. Contrast Media Mol Imaging 1:184–188
Moskowitz KA, Budzynski AZ (1994) The (DD)E complex is maintained by a composite fibrin polymerization site. Biochemistry 33:12937–12944
Tymkewycz PM, Creighton-Kempsford LJ, Hockley D et al (1992) Screening for fibrin specific monoclonal antibodies: the development of a new procedure. Thromb Haemost 68:48–53
Yilmaz A, Ulaka FS, Batun MS (2004) Proton T1 and T2 relaxivities of serum proteins. Magn Reson Imaging 22:683–688
Giesel FL, von Tengg-Kobligk H, Wilkinson ID et al (2006) Influence of human serum albumin on longitudinal and transverse relaxation rates (R 1 and R 2) of magnetic resonance contrast agents. Investig Radiol 41:222–228
Bogdanov A Jr, Mazzanti ML (2011) Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol 38:42–54
Nair SA, Kolodziej AF, Bhole G et al (2008) Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus. Angew Chem Int Ed Engl 47:4918–4921
Borsig L (2010) Antimetastatic activities of heparins and modified heparins. Experimental evidence. Thromb Res 125(Suppl 2):S66–S71
Tei L, Aime S, Uggeri F et al (2008) Accurate delineation of prostate cancer region by fibrin targeting MRI agents in TRAMP mouse model, World Molecular Imaging Congress, Nice, France
Tei L, Mazooz G, Shellef Y et al (2010) Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity. Contrast Media Mol Imaging 5:213–222
Acknowledgments
This research was supported by funding from AIRC Investigator Grant—IG 2013, prog. N.14565 (S.A.). ESF COST Action TD1004 is also acknowledged. The authors thank Simona Ramponi and Adriana Grotti, CRB Bracco Imaging S.p.A., for technical assistance and support with tumor model.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 6092 kb)
Rights and permissions
About this article
Cite this article
Chaabane, L., Tei, L., Miragoli, L. et al. In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing Peptide. Mol Imaging Biol 17, 819–828 (2015). https://doi.org/10.1007/s11307-015-0846-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-015-0846-4